Literature DB >> 23455326

Roles of microRNAs during prostatic tumorigenesis and tumor progression.

Y-X Fang1, W-Q Gao2.   

Abstract

Prostate cancer (PCa) is considered to be a frequently diagnosed cancer in males with high mortality worldwide, but the molecular mechanism responsible for prostate tumorigenesis and progression remains unclear. Increasing evidence has shown that microRNAs (miRNAs) play an important role in PCa. In this review, we focus on the current advances about the role of miRNAs in regulating tumorigenesis and progression of PCa, mainly in suppressing or promoting PCa growth and metastasis, and maintaining the pluripotency of PCa stem cells (PCSC). More studies on miRNAs will provide a better understanding of their regulatory mechanisms in PCa.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23455326     DOI: 10.1038/onc.2013.54

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  60 in total

1.  Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.

Authors:  C Coarfa; W Fiskus; V K Eedunuri; K Rajapakshe; C Foley; S A Chew; S S Shah; C Geng; J Shou; J S Mohamed; B W O'Malley; N Mitsiades
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

2.  Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.

Authors:  A Kroiss; S Vincent; M Decaussin-Petrucci; E Meugnier; J Viallet; A Ruffion; F Chalmel; J Samarut; N Allioli
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

3.  Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.

Authors:  Jia-Xuan Qiu; Zhi-Wei Zhou; Zhi-Xu He; Ruan Jin Zhao; Xueji Zhang; Lun Yang; Shu-Feng Zhou; Zong-Fu Mao
Journal:  Drug Des Devel Ther       Date:  2015-01-07       Impact factor: 4.162

4.  Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification.

Authors:  Ghada Al-Kafaji; Harun Muayad Said; Mahmood Abduljalil Alam; Ziad Tarraq Al Naieb
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

5.  MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.

Authors:  Cecilia Dallavalle; Domenico Albino; Gianluca Civenni; Jessica Merulla; Paola Ostano; Maurizia Mello-Grand; Simona Rossi; Marco Losa; Gioacchino D'Ambrosio; Fausto Sessa; George N Thalmann; Ramon Garcia-Escudero; Andrea Zitella; Giovanna Chiorino; Carlo V Catapano; Giuseppina M Carbone
Journal:  J Clin Invest       Date:  2016-11-07       Impact factor: 14.808

6.  Prostate cancer cell proliferation is suppressed by microRNA-3160-5p via targeting of F-box and WD repeat domain containing 8.

Authors:  Ping Lin; Lijuan Zhu; Wenjing Sun; Zhengkai Yang; Hui Sun; Dong Li; Rongjun Cui; Xiulan Zheng; Xiaoguang Yu
Journal:  Oncol Lett       Date:  2018-04-16       Impact factor: 2.967

7.  MicroRNA-203 inhibits cellular proliferation and invasion by targeting Bmi1 in non-small cell lung cancer.

Authors:  Tengfei Chen; Chun Xu; Jun Chen; Cheng Ding; Zhenlei Xu; Chang Li; Jun Zhao
Journal:  Oncol Lett       Date:  2015-03-27       Impact factor: 2.967

8.  Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells.

Authors:  Piwen Wang; Tien Phan; David Gordon; Seyung Chung; Susanne M Henning; Jaydutt V Vadgama
Journal:  Mol Nutr Food Res       Date:  2014-12-05       Impact factor: 5.914

9.  hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.

Authors:  Bin Xu; Tao Tao; Yiduo Wang; Fang Fang; Yeqing Huang; Shuqiu Chen; Weidong Zhu; Ming Chen
Journal:  Tumour Biol       Date:  2016-08-14

10.  Dissection of Individual Prostate Lobes in Mouse Models of Prostate Cancer to Obtain High Quality RNA.

Authors:  Areg Zingiryan; Nicholas H Farina; Kristiaan H Finstad; Janet L Stein; Jane B Lian; Gary S Stein
Journal:  J Cell Physiol       Date:  2016-04-01       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.